According to a new Dartmouth study published in JAMA Internal Medicine, pharmaceutical companies’ promotional access to outpatient practices that deliver primary care in the U.S.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
